Effect of pH and electrolytes on the colloidal stability of stearic acid–based lipid nanoparticles
Source abstract
Abstract
Stearic acid–based solid lipid nanoparticles, stabilised with Tween® 20, were synthesised using a microwave-assisted microemulsion technique and their stability was tested in simulated blood plasma, several liquids mimicking gastrointestinal fluids and solutions containing different electrolyte compositions and pH levels. It was discovered that simulated blood plasma had a stabilising effect on the particles, as did simulated saliva and intestinal fluid, which was due to hydration forces, facilitated by the presence of hydrated cations. It was determined that the hydration stabilisation was pH dependent, with highly acidic conditions depriving the solid lipid nanoparticles of the negative charge required for the cations to hydrate the surface. In environments lacking hydrated cations, the particles were predominately reliant on steric stabilisation and were particularly susceptible to pH extremes due to hydrolysis/oxidation of the Tween® 20 layer. The results suggest that the SLNs have potential as a systemic drug carrier, as the physicochemical conditions of blood provide a stabilising environment that inhibits particle growth.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Lipid Membrane Structure and Behavior · Surfactants and Colloidal Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (31)
Show source-provided references
1. Agha-Hosseini F, Dizgah IM, Amirkhani S (2006) The composition of unstimulated whole saliva of healthy dental students. J Contemp Dent Pract 7:104–11110.5005/jcdp-7-2-104 ↗
2. Bates TR, Nightingdale CH, Dixon E (1973) Kinetics of hydrolysis of polyoxyethylene (20) sorbitan fatty acid ester surfactants. J Pharm Pharmacol 25:470–47710.1111/j.2042-7158.1973.tb09135.x ↗
3. Das S, Chaudhury A (2011) Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 12:62–7610.1208/s12249-010-9563-0 ↗
4. Elsabahy M, Wooley KL (2012) Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 41:2545–256110.1039/c2cs15327k ↗
5. Freitas C (1999) Stability determination of solid lipid nanoparticles (SLN TM) in aqueous dispersion after addition of electrolyte. J Microencapsul 16:59–7110.1080/026520499289310 ↗
6. Freitas C, Müller RH (1999) Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur J Pharm Biopharm 47:125–13210.1016/S0939-6411(98)00074-5 ↗
7. Guo X, Szoka FC (2001) Steric stabilization of Fusogenic liposomes by a low-pH sensitive PEG−Diortho Ester−lipid conjugate. Bioconjug Chem 12:291–30010.1021/bc000110v ↗
8. He C, Hu Y, Yin L, Tang C, Yin C (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657–366610.1016/j.biomaterials.2010.01.065 ↗
9. Heurtault B, Saulnier P, Pech B, Proust J-E, Benoit J-P (2003) Physico-chemical stability of colloidal lipid particles. Biomaterials 24:4283–430010.1016/S0142-9612(03)00331-4 ↗
10. Lindahl A, Ungell A-L, Knutson L, LennernÄS H (1997) Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res 14:497–50210.1023/A:1012107801889 ↗
11. López-León T, Santander-Ortega MJ, Ortega-Vinuesa JL, Bastos-González D (2008) Hofmeister effects in colloidal systems: influence of the surface nature. J Phys Chem C 112:16060–1606910.1021/jp803796a ↗
12. Marques MR, Loebenberg R, Almukainzi M (2011) Simulated biological fluids with possible application in dissolution testing. Dissolut Technol 18:15–2810.14227/DT180311P15 ↗
13. Mccance R (1938) The effect of salt deficiency in man on the volume of the extracellular fluids, and on the composition of sweat, saliva, gastric juice and cerebrospinal fluid. J Physiol 92:208–21810.1113/jphysiol.1938.sp003595 ↗
14. Mehnert W, Mäder K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–19610.1016/S0169-409X(01)00105-3 ↗
15. Morachis JM, Mahmoud EA, Almutairi A (2012) Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. Pharmacol Rev 64:505–51910.1124/pr.111.005363 ↗
16. Mukherjee S, Ray S, Thakur RS (2009) Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 71:349–35810.4103/0250-474X.57282 ↗
17. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur J Pharm Biopharm 50:161–17710.1016/S0939-6411(00)00087-4 ↗
18. Oyane A, Kim HM, Furuya T, Kokubo T, Miyazaki T, Nakamura T (2003) Preparation and assessment of revised simulated body fluids. J Biomed Mater Res A 65:188–19510.1002/jbm.a.10482 ↗
19. Peula-García JM, Ortega-Vinuesa JL, Bastos-González D (2010) Inversion of Hofmeister series by changing the surface of colloidal particles from hydrophobic to hydrophilic. J Phys Chem C 114:11133–1113910.1021/jp912035v ↗
20. Schwarz C (1999) Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization. J Microencapsul 16:205–21310.1080/026520499289185 ↗
21. Shah R (2016) Microwave-assisted Production of Solid Lipid Nanoparticles. PhD Thesis, Swinburne University of Technology
22. Shah RM, Malherbe F, Eldridge D, Palombo EA, Harding IH (2014) Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique. J Colloid Interface Sci 428:286–29410.1016/j.jcis.2014.04.057 ↗
23. Shah R, Eldridge D, Palombo E, Harding I (2015) Lipid nanoparticles: production, characterization and stability. Springer10.1007/978-3-319-10711-0 ↗
24. Shah RM, Bryant G, Taylor M, Eldridge DS, Palombo EA, Harding IH (2016a) Structure of solid lipid nanoparticles produced by a microwave-assisted microemulsion technique. RSC Adv 6:36803–3681010.1039/C6RA02020H ↗
25. Shah RM, Eldridge DS, Palombo EA, Harding IH (2016b) Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs. Int J Pharm 515:543–55410.1016/j.ijpharm.2016.10.054 ↗
26. Shah RM, Eldridge DS, Palombo EA, Harding IH (2017) Microwave-assisted microemulsion technique for production of miconazole nitrate- and econazole nitrate-loaded solid lipid nanoparticles. Eur J Pharm Biopharm 117:141–15010.1016/j.ejpb.2017.04.007 ↗
27. Shah RM, Mata JP, Bryant G, De Campo L, Ife A, Karpe AV, Jadhav SR, Eldridge DS, Palombo EA, Harding IH (2018) Structure analysis of solid lipid nanoparticles for drug delivery: a combined USANS/SANS Study [Forthcoming]. Part Part Syst Charact 1800359
28. Shaw DJ (1992) Introduction to colloid and surface chemistry. Butterworth-Heinemann Ltd, Oxford
29. Tadros TF (2015) Interfacial phenomena and colloid stability: basic principles. De Gruyter, Berlin
30. Zhang L, Yadav S, Demeule B, Wang YJ, Mozziconacci O, SchӦneich C (2017) Degradation mechanisms of polysorbate 20 differentiated by 18O-labeling and mass spectrometry. Pharm Res 34:84–10010.1007/s11095-016-2041-y ↗
31. Zimmermann E, Müller RH (2001) Electrolyte-and pH-stabilities of aqueous solid lipid nanoparticle (SLN™) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm 52:203–21010.1016/S0939-6411(01)00167-9 ↗